Previous work linked the expression of the IL6 receptor (IL6R) α subunit (IL6Rα) and gp130, the signaling chain subunit of the IL6R, to IL6-mediated STAT3 activation in DLBCL [14]. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.